WealthPLAN Partners’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

WealthPLAN Partners’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,936	Closed	-$22	–	1145
2016 Q2	$22	Buy	+1,936	New	+$22	﹤0.01%	2480
2015 Q4	$1.41K	Buy	+1,936	New	+$1.72K	﹤0.01%	1520
2015 Q2	$6K	Buy	3,886 +389	+11%	+$926	﹤0.01%	339
2015 Q1	$10K	Buy	+3,497	New	+$13.8K	﹤0.01%	382

WealthPLAN Partners's RCPI Position: Q3 2016 in Review

WealthPLAN Partners sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2016, closing a stake of 1,936 shares — an estimated $22 sold.

WealthPLAN Partners first reported a position in RCPI in Q1 2015 and held it in 4 quarters. The position peaked at $10K in Q1 2015. 3 funds tracked by Wall St. Rank hold RCPI as of Q3 2016.

WealthPLAN Partners reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
WealthPLAN Partners sold 1,936 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $22.
WealthPLAN Partners first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 4 quarters.
WealthPLAN Partners's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $10K in Q1 2015.
3 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on WealthPLAN Partners's 13F filing for Q3 2016, filed 9 Dec 2016.